Connecticut Senate chamber interior
A 340B anti-discrimination bill targeting pharmacy benefit managers and drug manufacturers failed to advance in Connecticut.

State Bill That Would Have Stopped Drug Industry from Imposing 340B Contract Pharmacy Restrictions Dies

Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.

SB 355 originally focused only on forbidding pharmacy benefit managers (PBMs) from discriminating against 340B covered entities and their contract pharmacies but was expanded later.

Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer